ABS Report (Premium Edition) – Nov. 16, 2020
Stocks are up this morning because Moderna MRNA said its experimental vaccine candidate was 94.5% effective, according to interim analysis of its Phase 3 study. Morgan Stanley MS raised its S&P 500 price target to […]
ABS Report (Premium Edition) – Nov. 16, 2020 Read More »






